2023,Vol.37,No.3论文综述Primovist,eovist:whattoexpect?[J].JHepatol,2012,57(2):421429.[13]陈红松,窦晓光,段钟平,等.丙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):19611979.[14]KUDOM.Surveillance,diagnosis,treatment,andoutcomeoflivercancerinJapan[J].LiverCancer,2015,4(1):3950.[15]UENOA,MASUGIY,YAMAZAKIK,etal.OATP1B3expressionisstronglyassociatedwithWnt/β-cateninsignallingandrepresentsthetransporterofgadoxeticacidinhepatocellularcarcinoma[J].JHepatol,2014,61(5):10801087.[16]ZECHCJ,BA-SSALAMAHA,BERGT,etal.Consensusreportfromthe8thinternationalforumforlivermagneticresonanceimaging[J].EurRadiol,2020,30(1):370382.[17]牟焕晨,耿航,么荣荣,等.钆塞酸二钠增强MR与增强CT对小肝癌的诊断价值分析[J].微量元素与健康研究,2022,39(6):67.[18]HAMMERSTINGLR,HUPPERTZA,BREUERJ,etal.Diagnosticefficacyofgadoxeticacid(Primovist)-enhancedMRIandspiralCTforatherapeuticstrategy:comparisonwithintraoperativeandhistopathologicfindingsinfocalliverlesions[J].EurRadiol,2008,18(3):457467.[19]LIUXJ,JIANGHY,CHENJ,etal.Gadoxeticaciddisodium-enhancedmagneticresonanceimagingoutperformedmultidetectorcomputedtomographyindiagnosingsmallhepatocellularcarcinoma:ameta-analysis[J].LiverTranspl,2017,23(12):15051518.[20]LEESA,LEECH,JUNGWY,etal.ParadoxicalhighsignalintensityofhepatocellularcarcinomainthehepatobiliaryphaseofGd-EOB-DTPAenhancedMRI:initialexperience[J].MagnResonImaging,2011,29(1):8390.[21]WANGQ,WANGAR,SPARRELIDE,etal.Predictivevalueofgadoxeticacid-enhancedMRIforposthepatectomyliverfailure:asystematicreview[J].EurRadiol,2022,32(3):17921803.[22]邵佳,贺业新.应用Gd-EOB-DTPA增强MRI评价肝功能的研究进展[J].磁共振成像,2020,11(11):10561058.[23]陈国勇,李真林.DWI和肝胆特异性对比剂Gd-EOB-DTPA在肝局灶性病变诊断和鉴别诊断中的应用现状[J].四川大学学报(医学版),2022,53(5):737743.[24]周安,吕志彬,杜艳妮,等.钆塞酸二钠增强磁共振成像相对强化率与肝功能的相关性研究[J].新发传染病电子杂志,2021,6(2):8891.[25]PIANTANIDAE,IPPOLITOS,GALLOD,etal.Theinterplaybetweenthyroidandliver:implicationsforclinicalpractice[J].JEndocrino...
